drugset / Trial / NCT04136327

A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection

NCT04136327 ↗

Phase 1 Completed 6 enrolled Lakefront Biotherapeutics NV
Non-randomizedSequentialOpen-labelBasic science

Summary

The sponsor wants to investigate in this study how well the test medicine is taken up by the body when given orally (by mouth) as a tablet and solution, and as a solution for infusion (into a vein). The oral solution and solution for infusion will be radiolabelled. 'Radiolabelled' means that the test medicine has a radioactive component which helps us to track where the test medicine is in the body, what it is broken down into, and how it leaves the body. The sponsor will also look at the safety and tolerability of the test medicine.

Timeline

Start
2019-09-13
Primary completion
2019-10-21
Completion
2019-10-21

Drugs

EvaluationDrugModalityDoseRoute
Subject ALDUMASTAT Small molecule — Oral

Indications

No indication recorded.